Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    12504397 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders
Conditions: Neuromyelitis Optica;   Neuromyelitis Optica Spectrum Disorders
Intervention: Drug: Mitoxantrone
2 Not yet recruiting Intrathecal Methotrexate for Progressive Multiple Sclerosis: An Open Label Single Arm Study
Condition: To Evaluate the Effect of Therapy With IT MTX on the Disease Course of Patients With Progressive MS
Intervention: Drug: Intrathecal methotrexate
3 Unknown  Study to Evaluate the Reduction of Cardiac Problems in Multiple Sclerosis Patients With Mitoxantrone and Dexrazoxane in Combination
Condition: Multiple Sclerosis
Interventions: Drug: Dexrazoxane (DRZ) plus Mitoxantrone (MX);   Drug: Placebo plus Mitoxantrone (MX)

Study has passed its completion date and status has not been verified in more than two years.